Mark Pykett
10Patents
4h-index
10Co-inventors
57Inventor score
Filing activity: May 18, 2000 → Nov 30, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6440734B1 | Methods and devices for the long-term culture of hematopoietic progenitor cells | Chemistry; Metallurgy | 53 | Expired |
| US7192769B2 | Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices | Physics | 52 | Expired |
| US6548299B1 | Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices | Physics | 43 | Expired |
| US6645489B2 | Methods and devices for the long-term culture of hematopoietic progenitor cells | Chemistry; Metallurgy | 42 | Expired |
| US7067316B2 | Methods and devices for the long-term culture of hematopoietic progenitor cells | Chemistry; Metallurgy | 1 | Expired |
| US11116852B2 | Frataxin expression constructs | Chemistry; Metallurgy | 1 | Active |
| US10898585B2 | Gene therapy for AADC deficiency | Chemistry; Metallurgy | 0 | Active |
| US12409235B2 | Gene therapy for AADC deficiency | Chemistry; Metallurgy | 0 | Active |
| US11865188B2 | Gene therapy for AADC deficiency | Chemistry; Metallurgy | 0 | Active |
| US11998618B2 | Frataxin expression constructs | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.